week 3 Flashcards

1
Q

Hierarchy of regulatory mechanisms

A

DNA structure –presence, amplification, modification by porA/pili

Transcriptional regulation – activation,repression by sigma factor/fur

Post transcriptional regulation – translation repression, transcript stability by sRNA, riboswitch, RNAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gene

A

promoter, ORF, terminator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Operon

A

two or more genes connected all activated by a common promoter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Regulon

A

couple of genes alle regulated by the same regulator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stimulon

A

genes activated by the same stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Finetuning expression of genes why

A

Essential to adapt to growh conditions
Express virulence for pathogenesis and survival in host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

function promotor, sigma, shine delgarno

A

Promotor is recognized by RNA polymerase and sigma factor, which recognizes -30 and -10
shine dalgarno in transcriptional region but not translational region AG rich is recognized by ribosome, recognizes AGG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DNA sequence alterations;

A

Slipped strand mispairing – DNA polymerase slips forward of back, leads illegitimate base pairing of repetitive DNA during replication and to insertion or deletion. Way to alter gene expression but very random. Caused by triplets or stretches of the same nucleotides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

porA gene of n meningitidis

A

spacer becomes shorter, expression level of protein becomes less, because less binding strength RNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

transcriptional regulation
growth conditions

A

nutrients, oxygen, iron, glucose, pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

iron why needed in bacteria

A

needed to support growth, stimulus to produce new proteins used for survival (virulence factors). Could be potential vaccine candidates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

identify iron regulated proteins in bacteria

A

RNAseq. Grow bacteria with and without iron, isolate cDNA, how many transcripts are produced can be measured. mRNA, RNA fragments, DNA framgents, map against sequence, reading map

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

transcriptional regulation
sigma factor

A

in contact with -10 and -35, equipped with RNA polymerase. Some sigma can bind specific sequences. Sigma 70 for genes that are always on and are general, sigma 32 for stress, sigmaE whe heatshocked, sigma 54 when nitrogen is present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

mode of action of sigma factor

A

recognize sequence near promotor region, mode of action on repressor or activator protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mode of action of repressor protein

A

steric hindrance (spacer region blocked for RNAP), blocking elongation, DNA looping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mode of action of activator protein

A

class I activation, class II activation, conformation change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

sigma factor;

A

specific promotor sequence recognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

fur;

A

specific transcriptional regulator stimulated by Fe
A ferritine uptake regulator. Fur box is partly overlapping with promotor. Condition that there is a lot of iron present, fur will bind to fur box. No transcription is needed. Low iron – no binding fur to furbox, no transcription.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

iron responsive regulon –

A

lactoferrin/transferrin binding protein
pili
* kapsel
* iron-acquisition proteins
* proteins complexed with iron (enzymes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

sRNA –

A

encoded in intergenic region or anti sense strand
regulate stability and translation mRNA, multiple mRNA targets
antisense to the 5UTR of target mRNA that they regulate
environmental stress induces – induces stress response
some contain fur box

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

mechanisms of riboregulation

A

translational repression – binding RBS
translation activation – remove pin like structure
mRNA degradation
mRNA stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

four regulatory mechanisms per sRNA

A
  1. Coupled degradation: both sRNA and mRNA degraded
  2. Sequestration: both sRNA and mRNA stabilization
  3. Catalytic degradation: only mRNA degraded
  4. Activation: with Qrr degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

sRNA interaction with target

A

sRNA contains 4 stemloops that can disappear when bound to mRNA. When stemloop is intact, protein production is intact.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

No loop after binding sRNA

A

RNAse can bind and degrade mRNA and sRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

luxMN

A

degraded due to loss stemloop 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

luxO

A

not degraded due to stemloop 1 still being present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

riboswitches –

A

elements in 5UTR of mRNA
operates by changing structure in response to binding metabolite
translation is on when RBS is fee, but when RBS binds to anti RBS then translation is blocked. Different ligands to block translation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

RNATs

A

RNA thermometers
Also conformational change but due to temperature
RBS is in stemloop, when temperature raises RBS is free, ribosome can bind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Q fever symptoms

A
  • 60% asymptomatic
  • 20% fever like: headache, fever, nausea, muscle pain
  • 20% serious; fever, chest pain, severe head ache, diarrhoea, vomiting, atypical pneumonia (not reacting to normal AB), hepatitis, pericarditis, meningo encephalitis
  • 1-3% chronic (could be in any group); endocarditis and intravasculair infections. Increased risk in pregnant, vascular disease, intravascular patches. Leads to abortion, premature birth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Q fever cause

A

Coxiella burnetii
* Spores survive up to 40 months
* In rodents, birds, farming animals, cats, dogs, ticks. Mainly sheep, goats, cattle
* Found in dung, urine, milk etc, spread through dried excreta, air borne
* Very rarely contaminated food or ticks
Treatment; acute doxy 200mg 1dd 14d, chronic; combination therapy 18m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Diagnosis q fever

A
  • First 2 weeks pcr on dna Coxiella
  • Week 3 and later Ab detection phase 2 IgM IgG
  • Chromic; IgG phase 1
    How was origin of q fever found – abortus storm by goats
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Q fever policy of blood transfusion

A
  • Decided that it was not a threat
  • However – PCR on hottest samples, serology on half of group (follow up after second transfusion). ELISA serological plot has shown that 1/10 had antibodies in affected area
  • Could be transfused, however blood was needed so PCR tests were implemented
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Why weren’t farms shut down earlier after thousands of notifications

A

because of the financial impact of shutting down farms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Virulence –

A
  • competition
  • invasion
  • Sensing
  • Attachment
  • Overturning host defenses
  • Interference with host processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Secretion system

A

membrane complex
Secretion systems in gram negative cell envelope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

class 1-6 protein complexes

A

based upon order of discovery. Macromolecular structures present on surface; in part adaptation from pili, flagella, conjugation system
* One step – crosses both membranes, with help of chaperones and ATP
* Two step (2 and 5) – first inner membrane via sec/tat, periplasmic chaperones, no energy source at outer membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Crystallography

A

refraction of beam line when x ray shines on cristal
* Purified protein in large amount
* Prepare using precipitation (trial and error)
* Obtain diffraction pattern using x ray
* Determine structure from pattern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Crystallography not suitable for membrane proteins why

A
  • hydrophobic surface
  • aggregation rather than crystallization
  • difficult to purify in large amounts out of membrane
  • need to solubilize them using detergents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

electron microscopy

A

electron beams reflected by electron dense material
* biological samples need staining with heavy metals
* cyro EM – freezing at low temp. prevents radiation damage, no staining needed
* suitable for bacterial cells, sliced samples, purified complexes with lower concentrations, less pure, image averaging improves resolution and samples can be tilted which gives 3d tomography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

type III system

A

‘injection needle’ makes hole in eukaryotic cell, from cytosol bacteria to cytosol eukaryotic cell
* example; yersinia outer proteins (YOPS) secreted via type 3 modulate host cell processes
* intimate attachment and anti-apoptotic and anti-inflammatory signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

cryo-EM tomography of type III complex

A
  • prepare vitrified cells
  • perform tomography
  • image with EM
  • do averaging of identified complexed
  • no purification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

secretion system VI

A
  • two homologues of T4SS
  • IM and ATP binding
  • Other genes in cluster different from
43
Q

T4SS

A
  • Other bacteria carried similar genomic islands
  • Kill other bacteria
  • hcpI part between rings, very similar
44
Q

gpVN for phage tail

A
  • VrgG is also ring like with shaft like structure underneath
  • In conclusion – functions like bacteriophage
45
Q

Model of type VI secretion

A
  • Build up
  • Signalling
  • Contraction/ejection
  • Degradation
46
Q

What gets secreted using VI

A
  • Peptidoglycan degradation
  • Nucleases
  • Insertion into membrane – pore formation
47
Q

Where can VI excretion be found

A

in opportunistic bacteria when microflora is present

48
Q

What triggers VI

A
  • Defense system – 2 component regulatory system works as kinase system
  • Attack system – cell to cell contact. OmpA in outer membrane. Also periplasmic relay proteins such as TsIA, triggers assembly baseplate
49
Q

Autotransporters

A
  • secretion system consisting of one protein and three domains
  • Two step mechanism uses sec in inner membrane, to outer membrane protein
  • Folding outside is driving force of pulling protein out
50
Q

Hemoglobin protease

A

plasmid encoded virulence vector encoded by E coli. Degrades hemoglobin, peritonitis

51
Q

AFM

A

used to unfold and refold protein such as Hbp by lowering and lifting tip of machine.
* Release beta strand releases energy
* C terminal part is most stable part, most likely to emerge first from membrane

52
Q

Application of autotransporters

A
  • Vesicles (not whole bacteria) with non cleaved Hbp
  • However, more complex – less proteins produced
  • Hbp-spy system allows attaching proteins to outer membrane
  • Hbp secretion as target for novel antibiotics
53
Q

BamA

A

inhibition as target of drug inhibitors, since BamA is necessary for bacteria to survive

54
Q

Bcg vaccine

A

live attenuated strain, still used today but only partly effective (only in children)

55
Q

Treatment tuberculosis

A

antibiotic combination therapy

56
Q

Prevalence tuberculosis

A

Sub saharan africa, south asia

57
Q

Problem tuberculosis

A
  • Current vaccine does not protect enough
  • HIV and tuberculosis is deathly
  • Antibiotic resistance
  • Highly unusual and slow growing bacterium -20-24h doubling time
  • No optimal infection model
  • Envelope complicates analyses
58
Q

Infection cycle tuberculosis

A
  • Bacteria enters lungs, infects alveolar macrophages which form granulomas in response to immune response
  • Bacteria inside are still alive, T cells surrounding. No symptoms, can be stable for decades and is called latent TB
  • Reactivation and caseation of center; replicate and spread leads to active TB
59
Q

Disseminated TB

A
  • Lungs first
  • Meninges
  • Intestines
  • Milk duct
  • Bones
60
Q

Tissue damage and death due to m tuberculosis

A
  • Not toxins, which give little direct cell damage
  • Due to granuloma and weight loss due to pro inflammatory cytokines
61
Q

Micobacteria

A

different types, usually slow growth rate
Fast growth rate = 1-2 hours

62
Q

Mycobacterial cell envelope

A

more than 60% lipids, not permeable leads to virulence. Also gram variable

63
Q

Gram staining characteristics

A
  • Gram positive had One membrane and thick peptidoglycan
  • Gram negative has two membranes and thin peptidoglycan layer
  • Mycobacteria – mycobacterial outer membrane, no LPS, contain arabinogalactan and peptidoglycan. So it has two membranes but still stains a bit sometimes
64
Q

TB survival inside macrophage

A

phagosome doesn’t fuse with lysosome, also can escape phagosome

65
Q

Escape of TB visualization

A
  • Galectin 3 in macrophage labeled with GFP. Once there is damage it binds to damaged membrane
66
Q

Esx5 in TB

A

is essential for growth. When outer layer of membrane is mutated, this complex is not essential anymore. Only seen in slow growing mycobacteria. Required for uptake of fatty acids
mspA found in fast growing, essential for growth. Alleviates essentiality of esx5

67
Q

how do ATPase channels open up for transport, and how are they transported through the outer membrane?

A

No answer yet

68
Q

HGT and population structure

A
  • Population with diversity reduction – mutations that bring burden decrease in diversity. Focused towards clones that adapted best
  • With horizontal transfer – adaptations to possible problems to come
  • Clone dominance
69
Q

Genome

A

all chromosomes and plasmids. Bacterial often circular, can be linear. Plasmids are smaller DNA elements that are circular. Megaplasmids and small chromosomose hard to distinguish. No plasmid transfer then its probably chromosome.

70
Q

Mechanisms of HGT

A
  • Bacterial transformation – take up DNA
  • Bacterial transduction - bacteriophage
  • Bacterial conjugation – bridge two bacteria
71
Q

Transposons

A
  • Jumping gene
  • Replicating and inserting somewhere else
  • Requirements – gene encoding transposase, flanked by inverted repeat sequences
72
Q

Composite transposon

A

additional gene between flanking inverted repeats or insertion sequences

73
Q

Insertion sequence

A

on host chromosome and plasmid, can align and cross and therefore plasmid can integrate into host genome

74
Q

Restriction modification (RM) sequences

A

to neutralize incoming DNA. Incoming DNA gets digested by REase, but not when DNA is methylated, then it attacks own DNA.

75
Q

Role of RM in recombination

A

before getting degraded can associate via chi sequence on DNA and integrate
* Mostly in opportunistic pathogens – if they collect all types of foreign DNA it leads to combinations that help survive. Less in obligate pathogens because they live mostly in one site

76
Q

Pathogenicity/genomic island

A
  • Contains genes associated with virulence, regulation and mobilituy
  • Inserted in single site, often adjacent to tRNA gene
  • Different GC content
  • Some pathogenicity islands (PAIs) hijack a phage to spread; PICI, phage-inductible chromosomal islands
77
Q

Applciations of bacterial genome plasticity

A
  • Diagnostic marker
  • Diagnostic antigen
  • Marker for prognosis
  • Vaccine candidates
  • Outbreak investigation
78
Q

MRSA test

A

mecA gene encoded, can be tested by PCR

79
Q

s aureus kenmerken

A
  • gram positive
  • spherical shaped
  • around 30% carries in their nose
  • can infect all barrier tissues
80
Q

health care burden s aureus

A
  • recurrent infections, so no protective immunity
  • rise in resistance
  • s aureus in blood is lethal in 20%
81
Q

s aureus vaccine development

A
  • we don’t know the precise correlates of protection (signs that host is immune)
  • insights from immune defects associated with s aureus infection (neutrophils and T cells)
82
Q

neutrophils kenmerken

A
  • most abundant in blood (40%)
  • polymorphic nucleus
  • short lived
  • granules with antimicrobial peptides; hydrolases, peroxidases etc
  • migration via chemotaxis
83
Q

killing s aureus by neutrophils

A
  • netosis
  • phagocytosis
  • stimulated by phagocytosis, T cells, antibodies, components
84
Q

s aureus vaccine hurdles

A
  • immune evasion
  • translation
  • strain variation
85
Q

Immune evasion by s aureus problem for vaccine development

A
  • Evasion of opsonization – proteins that counteract Ab binding to s aureus. Can inhibit complement by binding c3 convertase.
  • Evasion of phagocytosis and killing – blocking recruitment, blocking phagocytosis, blocking NET formation, blocking formation proteases
  • Targeting immune cells – toxins that form pores in immune cells. Superantigens activate more t cells (25% activation instead of 2% leading to exhaustion)
86
Q

Translation pre clinical studies to humans problem for s aureus vaccine development

A
  • LD50 (dose needed for 50% mortality) differs a lot per animal, unknown for human
  • Not all species have same pore forming toxins
87
Q

Merck vaccine

A

iron regulated surface derterminant protein B (IsdB), immunogenic antigen. Goal to produce antibodies. Seemed to work in animals, but higher mortality in humans. Pre existing immunity leads to failure of the vaccine.

88
Q

Strain variation hurdle in s aureus problem for vaccine development
staphVAX vaccine

A

targets polysaccharides (CPS). Promising in mice. In humans ineffective

89
Q

future vaccines against s aureus focus

A
  • neutralize immune evasion (antibodies)
  • models that better resemble human infections
  • target conserved or essential bacterial antigens
90
Q

vaccine strategies
microbiome function

A
  • food digestion
  • vitamin production
  • colonizationresistance
  • educates immune system
  • but, can also contain potential pathogens
91
Q

vaccine with toxin neutralization

A

prevents cytolysis of host target cells by production Ab to neutralize toxin

92
Q

vaccine promoting recognition and killing

A

pore is formed leading to lysis by activating the complement system. Only works for gram negative. Phagocytosis and killing can be done in gram negative and positive by coating with antibody.

93
Q

Capsular polysaccharides (CPS) as virulence

A
  • Encapsulated bacteria have the ability or cause invasive disease
  • Cps composition differs between species but also within species – diagnostic value
  • CPS are important virulence factors by providing resistance phagocytosis and killing, resistance to serum killing
94
Q

Serogroup

A

determined by polysaccharide composition. In meningitis A, B, C, W and Y most prevalent diseasae causing

95
Q

Negative correlation antibodies and invasive disease in meningitis

A
  • Low incidence in newborns due to high levels of antibodies
96
Q

Plain polysaccharide vaccines

A
  • Protection provided with several drawbacks
  • Not immunogenic in young children because immune system is not developed enough
  • No memory, repeated immunizations needed
  • Limited class switching, only IgM, IgG
  • Ineffective against carriage, only individual protectio
97
Q

Protein conjugation vaccine

A
  • Extract polysaccharide, chemically link it to protein
  • Provides immunological memory with class switching and maturation - high IgG
  • Effective in infants
  • Herd immunity by reducing carriage and transmission
98
Q

Limitations CPS vaccine

A
  • Coverage is limited to subgroup of max 20 (while s pneumonae has 90 serotypes for example)
  • Glycan antigen is not immunogenic
  • Glycan structures are similar to human structures
  • Non encapsulated strains not covered
99
Q

GAS

A
  • Pyogenes, group A
  • Gram positive cocci
  • Hemolytic
  • Humans are only reservoir
  • Strain diversity for epidemiological surveillance; variation in emm gene
100
Q

GAS infection

A
  • Common commensal of skin and nasopharynx
  • Superficial infections, which can lead to invasive infections (flesh eating, sepsis) and post infectious/immune sequelae
101
Q

Why is there no GAS vaccine

A
  • Global diversity in desease causing strains, highly conserved vaccine target
  • Autoreactivity of possible vaccine targets – antigens should not induce autoimmunity
  • Capsule mimics host hyaluronan – autoimmunity
102
Q

GAC modify vaccine

A

to keep the vaccine function but without autoimmunity
Making mutants to see if it changes the physiology or biosynthesis (reverse genetics)
Found gene deletion that creates mutant glycoprotein structure – not as virulent
No cross reactivity with heart antigen

103
Q

FATAL FLAW SLIDE AANVULLEN

A

jo